|Bid||100.00 x 1200|
|Ask||181.94 x 900|
|Day's Range||181.13 - 184.64|
|52 Week Range||98.37 - 212.62|
|Beta (5Y Monthly)||0.49|
|PE Ratio (TTM)||20.27|
|Earnings Date||Aug 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||214.56|
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
United Therapeutics (UTHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2021 financial results before the market opens on Wednesday, August 4, 2021.